Giles Johnstone-Scott
Medicxi Ventures Management (jersey) Ltd
Assets Managed
$981.805M
Holdings
4
Last Quarter
2026 - Q1
Filed Date
2mo 3d ago
Growth Rate
17.59%(2Q avg: 14.88%)
Sustained Growth
3 quarters
Portfolio positions
This chart displays the top 10 holdings in Medicxi Ventures Management (jersey) Ltd's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 4 positions.
Assets under management
The assets under management (AUM) of Medicxi Ventures Management (jersey) Ltd over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 981.805M in assets, with a quarterly growth rate of 17.59% and a 2-quarter average growth rate of 14.88%. The portfolio is managed by Giles Johnstone-Scott, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
CNTA Centessa Pharmaceuticals-adr
| 80.77% | $792.937M 19.963M shares@ $39.72 avg price | |
NAMS Newamsterdam Pharma Co Nv
| 8.72% | $85.601M 2.674M shares@ $32.02 avg price | Decreased -6.8% |
PHAT Phathom Pharmaceuticals Inc
| 8.45% | $82.931M 7.465M shares@ $11.12 avg price | |
AURA Aura Biosciences Inc
| 2.08% | $20.337M 3.04M shares@ $6.69 avg price |
1-4 of 4